Enact (ACT) Stock Forecast, Price Target & Predictions
ACT Stock Forecast
Enact stock forecast is as follows: an average price target of $30.33 (represents a -16.54% downside from ACT’s last price of $36.34) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
ACT Price Target
The average price target for Enact (ACT) is $30.33 based on 1-year price targets from 10 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $25.00. This represents a potential -16.54% downside from ACT's last price of $36.34.
ACT Analyst Ratings
According to 10 Wall Street analysts, Enact's rating consensus is 'Buy'. The analyst rating breakdown for ACT stock is 0 'Strong Buy' (0.00%), 5 'Buy' (50.00%), 4 'Hold' (40.00%), 1 'Sell' (10.00%), and 0 'Strong Sell' (0.00%).
Enact Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 21, 2024 | Doug Harter | UBS | $33.00 | $31.08 | 6.18% | -9.19% |
| May 06, 2024 | Soham Bhonsle | BTIG | $33.00 | $31.31 | 5.40% | -9.19% |
| Feb 08, 2023 | - | J.P. Morgan | $25.00 | $23.02 | 8.60% | -31.21% |
| Jul 08, 2022 | - | BTIG | $27.00 | $21.66 | 24.65% | -25.70% |
The latest Enact stock forecast, released on May 21, 2024 by Doug Harter from UBS, set a price target of $33.00, which represents a 6.18% increase from the stock price at the time of the forecast ($31.08), and a -9.19% decrease from ACT last price ($36.34).
Enact Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $33.00 |
| Last Closing Price | $36.34 | $36.34 | $36.34 |
| Upside/Downside | -100.00% | -100.00% | -9.19% |
In the current month, the average price target of Enact stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Enact's last price of $36.34. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 05, 2024 | BTIG | Buy | Buy | Hold |
| May 21, 2024 | UBS | Neutral | Neutral | Hold |
| May 06, 2024 | BTIG | Buy | Buy | Hold |
| May 09, 2023 | Goldman Sachs | - | Neutral | Downgrade |
| May 09, 2023 | Atlantic Equities | - | Neutral | Downgrade |
| May 09, 2023 | Oppenheimer | - | Perform | Downgrade |
| May 09, 2023 | New Street | - | Buy | Initialise |
| May 09, 2023 | Barclays | - | Underweight | Downgrade |
| May 09, 2023 | Guggenheim | - | Buy | Upgrade |
| May 09, 2023 | Jefferies | - | Buy | Upgrade |
Enact's last stock rating was published by BTIG on Aug 05, 2024. The company gave ACT a "Buy" rating, the same as its previous rate.
Enact Financial Forecast
Enact Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $296.19M | $299.04M | $277.52M | $280.94M | $276.84M | $275.07M | $273.54M | $173.00K | $272.88M | $280.44M |
| Avg Forecast | $334.84M | $330.91M | $325.88M | $322.47M | $321.43M | $317.25M | $314.57M | $309.11M | $308.48M | $305.72M | $299.40M | $294.12M | $276.83M | $259.87M | $251.44M | $226.17M | $237.97M | $238.05M | $235.93M | $272.33M | $279.53M | $280.01M |
| High Forecast | $336.88M | $332.92M | $327.86M | $324.43M | $323.38M | $319.18M | $316.48M | $310.99M | $310.36M | $307.58M | $301.22M | $295.91M | $278.52M | $263.72M | $252.97M | $227.54M | $239.41M | $239.50M | $236.65M | $273.15M | $280.37M | $280.86M |
| Low Forecast | $332.96M | $329.05M | $324.04M | $320.65M | $319.62M | $315.46M | $312.80M | $307.37M | $306.75M | $304.00M | $297.72M | $292.46M | $275.27M | $255.06M | $250.03M | $224.89M | $236.63M | $236.71M | $235.27M | $271.57M | $278.75M | $279.23M |
| # Analysts | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | - | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.15% | 1.10% | 1.24% | 1.16% | 1.16% | 1.16% | 0.00% | 0.98% | 1.00% |
Enact's average Quarter revenue forecast for Mar 24 based on 0 analysts is $294.12M, with a low forecast of $292.46M, and a high forecast of $295.91M. ACT's average Quarter revenue forecast represents a -0.70% decrease compared to the company's last Quarter revenue of $296.19M (Dec 23).
Enact EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | - | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $213.10M | $213.06M | $237.58M | $196.04M | $257.52M | $273.67M | $222.68M | $207.64M | $187.37M |
| Avg Forecast | $181.41M | $179.28M | $176.55M | $174.70M | $174.14M | $171.88M | $170.43M | $167.47M | $167.13M | $165.63M | $162.21M | $159.35M | $149.98M | $140.79M | $136.23M | $122.53M | $128.93M | $195.80M | $127.82M | $177.62M | $151.44M | $178.00M |
| High Forecast | $182.51M | $180.37M | $177.63M | $175.77M | $175.20M | $172.92M | $171.46M | $168.49M | $168.15M | $166.64M | $163.20M | $160.32M | $150.89M | $142.88M | $137.05M | $123.28M | $129.71M | $234.96M | $128.21M | $213.14M | $151.90M | $213.60M |
| Low Forecast | $180.39M | $178.27M | $175.56M | $173.72M | $173.16M | $170.91M | $169.47M | $166.52M | $166.19M | $164.70M | $161.30M | $158.45M | $149.14M | $138.18M | $135.46M | $121.84M | $128.20M | $156.64M | $127.47M | $142.09M | $151.02M | $142.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.51% | 1.56% | 1.94% | 1.52% | 1.32% | 2.14% | 1.25% | 1.37% | 1.05% |
1 analysts predict ACT's average Quarter EBITDA for Dec 23 to be $149.98M, with a high of $150.89M and a low of $149.14M. This is -29.62% lower than Enact's previous annual EBITDA (Sep 23) of $213.10M.
Enact Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | - | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $157.31M | $164.19M | $168.02M | $175.99M | $143.81M | $190.99M | $204.74M | $164.63M | $153.53M | $137.21M |
| Avg Forecast | $191.28M | $190.75M | $190.28M | $183.14M | $175.16M | $174.68M | $168.32M | $164.04M | $155.46M | $157.93M | $158.75M | $151.62M | $145.60M | $141.04M | $132.48M | $127.04M | $133.45M | $143.38M | $138.64M | $131.31M | $131.26M | $130.35M |
| High Forecast | $192.79M | $192.26M | $191.79M | $184.59M | $176.54M | $176.07M | $169.66M | $165.34M | $156.69M | $173.57M | $160.01M | $152.82M | $146.75M | $153.72M | $133.53M | $128.04M | $134.50M | $172.06M | $139.18M | $157.57M | $131.78M | $156.42M |
| Low Forecast | $189.88M | $189.36M | $188.89M | $181.80M | $173.88M | $173.41M | $167.09M | $162.84M | $154.33M | $140.73M | $157.59M | $150.52M | $144.53M | $126.78M | $131.52M | $126.11M | $132.47M | $114.71M | $138.14M | $105.05M | $130.78M | $104.28M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.16% | 1.27% | 1.39% | 1.08% | 1.33% | 1.48% | 1.25% | 1.17% | 1.05% |
Enact's average Quarter net income forecast for Mar 24 is $151.62M, with a range of $150.52M to $152.82M. ACT's average Quarter net income forecast represents a -3.61% decrease compared to the company's last Quarter net income of $157.31M (Dec 23).
Enact SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | - | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Enact's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ACT last annual SG&A of $NaN (undefined).
Enact EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | - | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.98 | $1.03 | $1.04 | $1.08 | $0.88 | $1.17 | $1.26 | $1.01 | $0.94 | $0.84 |
| Avg Forecast | $1.21 | $1.20 | $1.20 | $1.15 | $1.10 | $1.10 | $1.06 | $1.03 | $0.98 | $1.00 | $1.00 | $0.96 | $0.92 | $0.89 | $0.84 | $0.80 | $0.84 | $0.87 | $0.87 | $0.84 | $0.83 | $0.80 |
| High Forecast | $1.22 | $1.21 | $1.21 | $1.16 | $1.11 | $1.11 | $1.07 | $1.04 | $0.99 | $1.09 | $1.01 | $0.96 | $0.93 | $0.97 | $0.84 | $0.81 | $0.85 | $0.88 | $0.88 | $0.84 | $0.83 | $0.81 |
| Low Forecast | $1.20 | $1.19 | $1.19 | $1.15 | $1.10 | $1.09 | $1.05 | $1.03 | $0.97 | $0.89 | $0.99 | $0.95 | $0.91 | $0.80 | $0.83 | $0.80 | $0.84 | $0.86 | $0.87 | $0.84 | $0.82 | $0.80 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.16% | 1.24% | 1.35% | 1.05% | 1.35% | 1.44% | 1.20% | 1.14% | 1.04% |
According to 0 Wall Street analysts, Enact's projected average Quarter EPS for Mar 24 is $0.96, with a low estimate of $0.95 and a high estimate of $0.96. This represents a -2.43% decrease compared to ACT previous annual EPS of $0.98 (Dec 23).
Enact Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MBI | MBIA | $3.61 | $14.00 | 287.81% | Buy |
| JRVR | James River Group | $6.56 | $10.67 | 62.65% | Buy |
| AMBC | Ambac Financial Group | $11.17 | $18.00 | 61.15% | Buy |
| ESNT | Essent Group | $63.49 | $73.75 | 16.16% | Buy |
| AGO | Assured Guaranty | $80.85 | $84.00 | 3.90% | Buy |
| NMIH | NMI | $41.15 | $41.00 | -0.36% | Buy |
| ACT | Enact | $36.34 | $30.33 | -16.54% | Buy |
| MTG | MGIC Investment | $25.30 | $20.67 | -18.30% | Buy |
| RDN | Radian Group | $35.15 | $27.63 | -21.39% | Buy |
ACT Forecast FAQ
Is Enact a good buy?
Yes, according to 10 Wall Street analysts, Enact (ACT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 50.00% of ACT's total ratings.
What is ACT's price target?
Enact (ACT) average price target is $30.33 with a range of $25 to $33, implying a -16.54% from its last price of $36.34. The data is based on 10 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Enact stock go up soon?
According to Wall Street analysts' prediction for ACT stock, the company can go down by -16.54% (from the last price of $36.34 to the average price target of $30.33), down by -9.19% based on the highest stock price target, and down by -31.21% based on the lowest stock price target.
Can Enact stock reach $50?
ACT's average twelve months analyst stock price target of $30.33 does not support the claim that Enact can reach $50 in the near future.
What are Enact's analysts' financial forecasts?
Enact's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.26B (high $1.27B, low $1.26B), average EBITDA is $683.91M (high $688.07M, low $680.07M), average net income is $682.21M (high $687.6M, low $677.22M), average SG&A $0 (high $0, low $0), and average EPS is $4.3 (high $4.34, low $4.27). ACT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.31B (high $1.32B, low $1.31B), average EBITDA is $711.94M (high $716.28M, low $707.94M), average net income is $755.45M (high $761.43M, low $749.93M), average SG&A $0 (high $0, low $0), and average EPS is $4.76 (high $4.8, low $4.73).
Did the ACT's actual financial results beat the analysts' financial forecasts?
Based on Enact's last annual report (Dec 2023), the company's revenue was $1.15B, beating the average analysts forecast of $1.01B by 13.74%. Apple's EBITDA was $0, missing the average prediction of $549.53M by -100.00%. The company's net income was $665.51M, beating the average estimation of $546.16M by 21.85%. Apple's SG&A was $0, beating the average forecast of $0 by 0%. Lastly, the company's EPS was $4.11, beating the average prediction of $3.44 by 19.33%. In terms of the last quarterly report (Dec 2023), Enact's revenue was $296.19M, beating the average analysts' forecast of $276.83M by 6.99%. The company's EBITDA was $0, missing the average prediction of $149.98M by -100.00%. Enact's net income was $157.31M, beating the average estimation of $145.6M by 8.04%. The company's SG&A was $0, beating the average forecast of $0 by 0%. Lastly, the company's EPS was $0.98, beating the average prediction of $0.918 by 6.73%